Smith Group Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Smith Group Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-950	Closed	-$64K	–	418
2019 Q3	$64K	Buy	+950	New	+$65.2K	﹤0.01%	266

Smith Group Asset Management's GHDX Position: Q4 2019 in Review

Smith Group Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 950 shares — an estimated $64K sold.

Smith Group Asset Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $64K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Smith Group Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Smith Group Asset Management sold 950 Genomic Health, Inc. shares in Q4 2019, an estimated $64K.
Smith Group Asset Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
Smith Group Asset Management's Genomic Health, Inc. position peaked at $64K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Smith Group Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.